Cefteram

CAS : 82547-58-8

Ref. 3D-AC19873

Informations sur le produit

• Nom: Cefteram
• Synonymes: (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyc lo[4.2.0]oct-2-ene-2-carboxylic acidAntibiotic ro 19-5247Cefterame2,2-Dimethylpropanoyloxymethyl (6R,7R)-7-[(Z)-2-(, (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 2,2-Dimethylpropanoyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-3-(5-methyl-2H-tetrazol-2-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-, [6R-[6α,7β(Z)]]-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-, (6R,7R)-, Antibiotic Ro 19-5247, Antibiotic T 2525, Cefterame, Ceftetrame, Ro 19-5247, T 2525

Description

Cefteram is a human serum derived drug that is used for the treatment of infectious diseases, such as tissue infections and urinary tract infections. It is a prodrug of ceftriaxone, which is an oral cephalosporin antibiotic. Cefteram is converted by hydrolysis to the active form of ceftriaxone in the intestines and then absorbed into the bloodstream. Cefteram has been shown to have pharmacokinetic properties similar to those of ceftriaxone in humans with normal kidney function. Cefteram has also been shown to be effective against bacteria resistant to penicillin-binding protein (PBP) inhibitors. Cell lysis occurs as a result of cefteram binding to PBP, which prevents bacterial cells from creating new cell walls.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 479.5 g/mol
• Formule: C₁₆H₁₇N₉O₅S₂
• Degré de pureté: Min. 95%
• Couleur/Forme: White To Off-White Solid